Tetrabenzyl-voglibose
98%
- Product Code: 51204
CAS:
115250-39-0
| Molecular Weight: | 627.77 g./mol | Molecular Formula: | C₃₈H₄₅NO₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, airtight, dry |
Product Description:
Used primarily in the research and development of diabetes treatments, this compound plays a crucial role in the study of alpha-glucosidase inhibitors. It helps in understanding how to effectively manage postprandial blood glucose levels by slowing carbohydrate digestion and absorption. Researchers utilize it to explore potential therapeutic agents that can improve glycemic control in patients with diabetes. Additionally, it serves as a valuable intermediate in the synthesis of more complex pharmaceutical compounds aimed at metabolic disorders. Its application is significant in advancing the development of novel medications that target enzyme inhibition to treat or manage diabetes more effectively.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White powder |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿8,980.00 |
+
-
|
| 0.250 | 10-20 days | ฿18,200.00 |
+
-
|
| 1.000 | 10-20 days | ฿53,000.00 |
+
-
|
Tetrabenzyl-voglibose
Used primarily in the research and development of diabetes treatments, this compound plays a crucial role in the study of alpha-glucosidase inhibitors. It helps in understanding how to effectively manage postprandial blood glucose levels by slowing carbohydrate digestion and absorption. Researchers utilize it to explore potential therapeutic agents that can improve glycemic control in patients with diabetes. Additionally, it serves as a valuable intermediate in the synthesis of more complex pharmaceutical compounds aimed at metabolic disorders. Its application is significant in advancing the development of novel medications that target enzyme inhibition to treat or manage diabetes more effectively.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :